Defense mechanisms against infections

Area of Science:

• Immunology
• Infectious Diseases
• Respiratory Medicine

Background:

• Respiratory infections are increasingly difficult to treat due to emerging microbes, opportunistic pathogens, and rising antibiotic resistance, particularly in Streptococcus pneumoniae.
• Pneumonia severity is exacerbated by a growing population of susceptible hosts, including immunocompromised individuals (due to medical therapy or HIV) and the elderly with comorbidities.

Purpose of the Study:

• To address the need for improved strategies against respiratory infections, focusing on enhancing host defenses and developing novel vaccination approaches.
• To explore innovative methods for immunizing the respiratory mucosal surface against pathogens like Streptococcus pneumoniae.

Main Methods:

• Investigating antigen-targeting strategies to deliver relevant antigens to airway antigen-processing cells, such as dendritic cells.
• Exploring the use of immunomodulatory cytokines, like interleukin-12, to enhance mucosal immune responses.

Main Results:

• Interleukin-12 demonstrates potential in stimulating mucosal antibody production (S-IgA and IgG) and promoting T lymphocyte responses.
• Interferon-gamma, induced by interleukin-12, can enhance macrophage-mediated microbial killing.

Conclusions:

• Novel vaccination strategies targeting respiratory mucosal surfaces are crucial for combating infections like Streptococcus pneumoniae.
• Utilizing cytokines such as interleukin-12 offers a promising avenue for boosting mucosal immunity and improving treatment outcomes for respiratory infections.